Here are five points:
1. The company’s shares rose by 5.8 percent in the last four weeks.
2. In four weeks, Integra LifeSciences outperformed the index by 3.11 percent.
3. The shares were under the S&P 500 by 6.89 percent in the past week.
4. In the past three months, Integra LifeSciences was up 5.12 percent.
5. The year-to-date stock performance checks in at 30.99 percent.
More articles on devices:
InVivo Therapeutics to present at Congress of Neurological Surgeons’ annual meeting: 5 quick facts
Z-Medical, WebOps partner for US launch of pedicle screw system: 4 takeaways
Spinal implant markets in US and Europe to continue growing: 5 observations
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
